FDA Clears Medtronic's And Boston Scientific's Remote Cardiac Monitors, Approves Abbott’s Bluetooth-Compatible ICDs
Medtronic will launch the LINQ II remotely programmable, insertable cardiac monitor in the US and Europe this summer following FDA clearance. Boston Scientific plans to launch its LUX-Dx monitor later this year. The agency also approved Abbott's Gallant ICD and CRT-D devices, which communicate with Abbott's myMerlinPulse mobile app.
You may also be interested in...
The deal is the fourth major acquisition in the remote monitoring market in the last five weeks after Philips acquired BioTelemetry and Capsule and Hillrom bought Bardy Diagnostics.
A new study shows implantable cardiac monitors are a cost-effective tool for preventing recurrent strokes following a stroke suspected to be caused by atrial fibrillation.
The randomized trial will evaluate the ability of the Reveal LINQ insertable monitor to help physicians prevent the progression of heart failure.